Editorial: The Association between Lymphocytic Thyroiditis and Papillary Thyroid Cancer

Authors

  • Alan Sacerdote Department of Medicine, Division of Endocrinology at: Woodhull Medical Center, SUNY Downstate Medical Center, NYU School of Medicine, And St. George’s University School of Medicine, Brooklyn, NY, USA
  • Taiga Inoue Department of Medicine, Division of Endocrinology at: Woodhull Medical Center, SUNY Downstate Medical Center, NYU School of Medicine, And St. George’s University School of Medicine, rooklyn, NY, USA

Abstract

Editorial

References

Meier DW, Woolner IB, Beahrs OH, McConahey WM. Parenchymal findings in thyroidal carcinoma: Pathologic study of 256 cases. J Clin Endocrinol Metab 1959; 19(1): 162-71. http://dx.doi.org/10.1210/jcem-19-1-162

Crile G Jr. hazard JB. Incidence of cancer in struma lymphomatosa. Surg gynecol Obstet 1962; 115: 101-3.

Tallini G, Asa SL. RET oncogene activation in papillary thyroid carcinoma. Adv Anat Pathol 2001; 8(6): 345-54. http://dx.doi.org/10.1097/00125480-200111000-00005

Nakazawa T, Kondo T, Kobayashi Y, Takamura N, Murata S, Kameyama K et al. RET gene rearrangements (RET/PTC1 and RET/PTC3 in papillary carcinoma from an iodine-rich country (Japan. Cancer 2005; 8(3): 943-51. http://dx.doi.org/10.1002/cncr.21270

Sheils OM, O’Eary JJ, Uhlmann V, lattich K, Sweeney EC. Ret/PTC-1 activation in Hashimoto’s thyroiditis. Int J Surg Pathol 8(3): 185-189. http://dx.doi.org/10.1177/106689690000800305

Nikiforova MN, Caudill CM, biddinger P, Nikiforova YE. Prevalence of RET/PTC rearrangements in Hashimoto’s thyroiditis and papillary thyroid carcinomas. Int J Surg Pathol 2002; 10(1): 15-22. http://dx.doi.org/10.1177/106689690201000104

Sugg SL, Ezzat S, Rosen IB, Freeman JL,Asa SL. Dinstinct multiple RET/PTC gene rearrangements in multifocal papillary thyroid neoplasia. J Clin Endocrinol Metab 1998; 83(11): 15-22.

Unger P, Ewart M, Wang BY, Gan L, Kohts DS, Burstein DE. Expression of p63 in papillary thyroid carcinoma and in hashimoto’s thyroiditis: a pathologic link? Hum Pathol 2003; 34(8): 764-9. http://dx.doi.org/10.1016/S0046-8177(03)00239-9

Kamma H, Fuji K, Ogata T. Lymphocytic infiltration in juvenile thyroid carcinoma. Cancer 1988; 62(9): 1988-93. http://dx.doi.org/10.1002/1097-0142(19881101)62:9<1988::AID-CNCR2820620919>3.0.CO;2-0

Schottenfeld D, Beebe-Dimmer J. Chronic inflammation: A common and important factor in the pathogenesis of neoplasia. CA Cancer J Clin 2006; 56: 69-83. http://dx.doi.org/10.3322/canjclin.56.2.69

Boelaert K, Horacek J, Holder RL, Wilkinson JC, Sheppard MC, et al. Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration. J Clin Endocrinol Metab 2006; 91(11): 4295-301. http://dx.doi.org/10.1210/jc.2006-0527

Hoevens GC, Stokkel MP, Kievet J, Corssmit EP, Pereira AM, Romijin JA, et al. Associations of serum thyrotropin concentrations with recurrence and death in differentiated thyroid cancer. J Clin Endocrinol Metab 2007; 92(7): 2610-5. http://dx.doi.org/10.1210/jc.2006-2566

Kim ES, Lim DJ, Baek KH, Lee JM, Kim MK, Kwon HS, et al. Thyroglobulin antibody is associated with increased cancer risk in thyroid nodules. Thyroid 2010; 20(8): 885-91. http://dx.doi.org/10.1089/thy.2009.0384

Downloads

Published

2016-03-30

Issue

Vol. 3 No. 3 (2015)

Section

Articles